U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536165) titled 'Extended Time Window Intravenous Tenecteplase Thrombolysis Registry for Acute Ischemic Stroke' on March 30.
Brief Summary: The EXTEND-TNK Registry is a prospective, multicenter, observational cohort study designed to evaluate the effectiveness and safety of intravenous tenecteplase administered beyond 4.5 hours after last known well in patients with acute ischemic stroke (AIS) in routine clinical practice across China.
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
Stroke
Acute Ischemic Stroke
Intervention:
DRUG: Tenecteplase
Intravenous tenecteplase 0.25 mg/kg (maximum 25 mg) administered as a single IV ...